In the last trading session, 1.09 million shares of the Skye Bioscience Inc (NASDAQ:SKYE) were traded, and its beta was 1.78. Most recently the company’s share price was $7.77, and it changed around -$1.16 or -12.99% from the last close, which brings the market valuation of the company to $218.10M. SKYE currently trades at a discount to its 52-week high of $19.41, offering almost -149.81% off that amount. The share price’s 52-week low was $1.44, which indicates that the current value has risen by an impressive 81.47% since then. We note from Skye Bioscience Inc’s average daily trading volume that its 3-month average coming to 98.93K.
Skye Bioscience Inc (NASDAQ:SKYE) trade information
Instantly SKYE has showed a red trend with a performance of -12.99% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently up 185.66% year-to-date, but still down -27.92% over the last five days. On the other hand, Skye Bioscience Inc (NASDAQ:SKYE) is -35.30% down in the 30-day period.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The consensus price target as assigned by Wall Street analysts is $20.67, which translates to bulls needing to increase their stock price by 62.41% from its current value. Analyst projections state that SKYE is forecast to be at a low of $20 and a high of $21.
Skye Bioscience Inc (SKYE) estimates and forecasts
Skye Bioscience Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 142.81 percent over the past six months and at a 82.31% annual growth rate that is well above the industry average of 15.20%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 32.94%.
SKYE Dividends
Skye Bioscience Inc’s next quarterly earnings report is expected to be released in July.
